Urinary pH as a Target in the Management of Lithiasic Patients in Real-World Practice: Monitoring and Nutraceutical Intervention for a Nonlithogenic pH Range

J. Galán-Llopis, C. Torrecilla-Ortiz, Maria Pilar Luque-Gálvez, Prevent-Lit Group, Xavier Peris-Nieto, Jordi Cuñé-Castellana
{"title":"Urinary pH as a Target in the Management of Lithiasic Patients in Real-World Practice: Monitoring and Nutraceutical Intervention for a Nonlithogenic pH Range","authors":"J. Galán-Llopis, C. Torrecilla-Ortiz, Maria Pilar Luque-Gálvez, Prevent-Lit Group, Xavier Peris-Nieto, Jordi Cuñé-Castellana","doi":"10.1177/1179561119853556","DOIUrl":null,"url":null,"abstract":"Introduction: We assessed the effectiveness of the joint use of a pH meter in combination with dietary supplements in restoring the urinary pH balance of patients with medical history of uric acid or calcium phosphate/calcium oxalate stones in real-world practice. Methods: An interventional, prospective, and open-label study was performed. At baseline visit, patients were assigned to a group according to the type of previous calculus and urinary pH: the alkalinizer group (uric acid stones and/or pH < 5.5) and acidifier group (calcium oxalate stones and/or pH > 6.2) received dietary supplement to increase or decrease, respectively, urinary pH. Patients were examined at baseline and after treatment for 30, 60, and 90 days. Urinary pH, type of therapy, compliance, and self-reported renal colic events were recorded at each visit. Results: The study included 143 patients, 45.5% in the alkalinizer group and 54.5% in the acidifier group, and the mean age was 53.60 years. Both nutraceuticals were significantly effective in normalizing urinary pH (P < 0.00001) at all follow-up visits compared with baseline, with a maximum percentage of patients who achieved nonlithogenic pH (54.9%) at day 60 (P < 0.00001). Analysis of the effect of treatment compliance at 60 days indicated that 71.8% of compliant and 45.9% of noncompliant patients achieved nonlithogenic pH (odds ratio [OR]: 3.03, 95% confidence interval [CI]: 1.29-6.66). A Cox-regression model indicated that nonlithogenic pH at 90 days (hazard ratio [HR]: 0.428, 95% CI: 0.193-0.947) and compliance at 60 days (HR: 0.428, 95% CI: 0.189-0.972) were independently associated with colic complaints-free survival. Conclusions: In patients with medical history of renal lithiasis, monitoring of pH in combination with dietary supplements may be useful in maintaining nonlithogenic pH values, yielding very high ratios of success, especially in compliant patients. Besides this main outcome, a reduction in self-reported colic complaints associated with pH balance was also observed.","PeriodicalId":89908,"journal":{"name":"Clinical medicine insights. Urology","volume":"30 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical medicine insights. Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1179561119853556","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: We assessed the effectiveness of the joint use of a pH meter in combination with dietary supplements in restoring the urinary pH balance of patients with medical history of uric acid or calcium phosphate/calcium oxalate stones in real-world practice. Methods: An interventional, prospective, and open-label study was performed. At baseline visit, patients were assigned to a group according to the type of previous calculus and urinary pH: the alkalinizer group (uric acid stones and/or pH < 5.5) and acidifier group (calcium oxalate stones and/or pH > 6.2) received dietary supplement to increase or decrease, respectively, urinary pH. Patients were examined at baseline and after treatment for 30, 60, and 90 days. Urinary pH, type of therapy, compliance, and self-reported renal colic events were recorded at each visit. Results: The study included 143 patients, 45.5% in the alkalinizer group and 54.5% in the acidifier group, and the mean age was 53.60 years. Both nutraceuticals were significantly effective in normalizing urinary pH (P < 0.00001) at all follow-up visits compared with baseline, with a maximum percentage of patients who achieved nonlithogenic pH (54.9%) at day 60 (P < 0.00001). Analysis of the effect of treatment compliance at 60 days indicated that 71.8% of compliant and 45.9% of noncompliant patients achieved nonlithogenic pH (odds ratio [OR]: 3.03, 95% confidence interval [CI]: 1.29-6.66). A Cox-regression model indicated that nonlithogenic pH at 90 days (hazard ratio [HR]: 0.428, 95% CI: 0.193-0.947) and compliance at 60 days (HR: 0.428, 95% CI: 0.189-0.972) were independently associated with colic complaints-free survival. Conclusions: In patients with medical history of renal lithiasis, monitoring of pH in combination with dietary supplements may be useful in maintaining nonlithogenic pH values, yielding very high ratios of success, especially in compliant patients. Besides this main outcome, a reduction in self-reported colic complaints associated with pH balance was also observed.
尿pH值作为现实世界中结石患者管理的目标:非致石性pH值范围的监测和营养干预
简介:我们评估了在现实世界中,联合使用pH计和膳食补充剂来恢复有尿酸或磷酸钙/草酸钙结石病史的患者尿液pH平衡的有效性。方法:进行一项介入性、前瞻性和开放标签的研究。在基线就诊时,患者根据既往结石类型和尿pH值被分为不同的组:碱化剂组(尿酸结石和/或pH值为6.2)分别服用膳食补充剂以增加或降低尿pH值。患者在基线和治疗后30,60和90天接受检查。每次就诊时记录尿pH值、治疗类型、依从性和自我报告的肾绞痛事件。结果:纳入143例患者,碱化组45.5%,酸化组54.5%,平均年龄53.60岁。与基线相比,这两种营养品在所有随访中均显著有效地使尿pH正常化(P < 0.00001),在第60天达到非结石性pH值的患者比例最大(54.9%)(P < 0.00001)。对60天治疗依从性的影响分析表明,71.8%的依从性患者和45.9%的不依从性患者达到了非结石性pH(优势比[OR]: 3.03, 95%可信区间[CI]: 1.29-6.66)。cox回归模型显示,90天非产石pH值(风险比[HR]: 0.428, 95% CI: 0.193-0.947)和60天依从性(风险比:0.428,95% CI: 0.189-0.972)与无绞痛生存独立相关。结论:对于有肾结石病史的患者,监测pH值并结合膳食补充剂可能有助于维持非结石性pH值,成功率非常高,特别是对依从性患者。除了这一主要结果外,还观察到与pH平衡相关的自我报告绞痛的减少。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信